niacin

Twenty Years of Nothing on Brain Cancer, and the Best New Lead Is a Vitamin Nobody Can Patent

A University of Calgary trial added high-dose niacin to standard glioblastoma treatment and reported 82% of 24 patients progression-free at six months. The design is single-arm and early, but the molecule is a cheap, unpatentable vitamin.